Cardio- and Neurotoxicity of Selected Anti-COVID-19 Drugs

Cardio- and Neurotoxicity of Selected Anti-COVID-19 Drugs

Since December 2019, the novel coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected ~435 million people and caused ~6 million related deaths as of March 2022. To combat COVID-19, there have been many attempts to repurpose FDA-appro...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Martin W. Nicholson, Ching-Ying Huang, Jyun-Yuan Wang, Chien-Yu Ting, Yu-Che Cheng, Darien Z. H. Chan, Yi-Chan Lee, Ching-Chuan Hsu, Yu-Hung Hsu, Cindy M. C. Chang, Marvin L. Hsieh, Yuan-Yuan Cheng, Yi-Ling Lin, Chien-Hsiun Chen, Ying-Ta Wu, Timothy A. Hacker, Joseph C. Wu, Timothy J. Kamp, Patrick C. H. Hsieh
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: MDPI AG 2022-06-01
Sarja:Pharmaceuticals
Aiheet:
stem cell research
cardiomyocyte
neuron
drug screening
human leukocyte antigen
human-induced pluripotent stem cell
Linkit:https://www.mdpi.com/1424-8247/15/6/765

Internet

https://www.mdpi.com/1424-8247/15/6/765

Samankaltaisia teoksia